BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.
Title | BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. |
Publication Type | Journal Articles |
Year of Publication | 2012 |
Authors | Lee SHee, Kalejta RF, Kerry J, Semmes OJohn, O'Connor CM, Khan Z, Garcia BA, Shenk T, Murphy E |
Journal | Proc Natl Acad Sci U S A |
Volume | 109 |
Issue | 24 |
Pagination | 9575-80 |
Date Published | 2012 Jun 12 |
ISSN | 1091-6490 |
Keywords | Cytomegalovirus, Cytomegalovirus Infections, Genes, Immediate-Early, HUMANS, Hydrolysis, MicroRNAs, Proteasome Endopeptidase Complex, Repressor Proteins, Tumor Suppressor Proteins |
Abstract | Cell proteins can restrict the replication of viruses. Here, we identify the cellular BclAF1 protein as a human cytomegalovirus restriction factor and describe two independent mechanisms the virus uses to decrease its steady-state levels. Immediately following infection, the viral pp71 and UL35 proteins, which are delivered to cells within virions, direct the proteasomal degradation of BclAF1. Although BclAF1 reaccumulates through the middle stages of infection, it is subsequently down-regulated at late times by miR-UL112-1, a virus-encoded microRNA. In the absence of BclAF1 neutralization, viral gene expression and replication are inhibited. These data identify two temporally and mechanistically distinct functions used by human cytomegalovirus to down-regulate a cellular antiviral protein. |
DOI | 10.1073/pnas.1207496109 |
Alternate Journal | Proc. Natl. Acad. Sci. U.S.A. |
PubMed ID | 22645331 |
PubMed Central ID | PMC3386064 |
Grant List | AI074800 / AI / NIAID NIH HHS / United States AI074984 / AI / NIAID NIH HHS / United States CA082396 / CA / NCI NIH HHS / United States GM071508 / GM / NIGMS NIH HHS / United States R01 CA076595 / CA / NCI NIH HHS / United States |